A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group (Sinopharm) in Beijing, capital of China, April 11, 2020.Photo:Xinhua

 
The United Arab Emirates health ministry said on Wednesday that an interim analysis of in-country Phase-III clinical trials of Sinopharm's COVID-19 vaccine shows it produced 86% efficacy against the virus.